Session Details
Oral Session 3 Management of Inflammatory Bowel Disease 3
Fri. Nov 20, 2026 10:15 AM - 11:05 AM JST
Fri. Nov 20, 2026 1:15 AM - 2:05 AM UTC
Fri. Nov 20, 2026 1:15 AM - 2:05 AM UTC
Room 9 (1F 101-A)
座長：横山 薫（北里大学医学部 消化器内科学）
[O3-1]Prediction of the Mayo Endoscopic Subscore (MES) Based on Clinical Symptoms and Biomarkers in Patients with Ulcerative Colitis
*Yusuke Asai1 (1. First Department of Medicine, Hamamatsu University School of Medicine)
[O3-2]Effectiveness and Predictive Factors for Remission after Twice-Weekly Granulocyte, Monocyte and Thrombocyte Apheresis Using Immunopure in Patients with Ulcerative Colitis
*Kohei Sugiyama1,2 (1. Sapporo IBD Clinic)
[O3-3]Investigation of the Usefulness of Serum Amyloid A as a Biomarker for Inflammatory Bowel Disease
*Kotaro Akita1 (1. Division of Gastroenterology and Hepatology, Department of Internal Medicine, Sapporo Medical University School of Medicine)
[O3-4]Surgical outcomes of medically refractory ulcerative colitis in the era of advanced therapies
*Satoru Morita1 (1. Department of Surgery, Keio University School of Medicine)
[O3-5]Comparison of Mucous Fistula Creation and Hartmann’s Procedure in Total Colectomy for Ulcerative Colitis
*Kensuke Shimbara1 (1. Department of Surgery, Graduate School of Biomedical ＆ Health Sciences, Hiroshima University,)
[O3-6]Comparative analysis of DNA methylation profiles in inflamed and remission colonic mucosa in ulcerative colitis
*Kaoruko Funakoshi1 (1. Department of Surgical Oncology, The University of Tokyo)
[O3-7]Two Cases of Refractory IBD Diagnosed as Familial Mediterranean Fever-Associated Enterocolitis Following Surgery
*Hiroshi Kuwabara1 (1. Department of Gastrointestinal and Pediatric Surgery, Tokyo Medical University)